<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" position="float">
 <label>Table 1</label>
 <caption>
  <p>Consensus criteria for a UIV.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="1" colspan="1"/>
    <th valign="top" align="left" rowspan="1" colspan="1">
     <bold>NIAID</bold>
    </th>
    <th valign="top" align="left" rowspan="1" colspan="1">
     <bold>WHO</bold>
    </th>
    <th valign="top" align="left" rowspan="1" colspan="1">
     <bold>BMGF</bold>
    </th>
    <th valign="top" align="left" rowspan="1" colspan="1">
     <bold>Consensus</bold>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Breadth</td>
    <td valign="top" align="left" rowspan="1" colspan="1">All influenza A viruses (influenza B protection would be the second target)</td>
    <td valign="top" align="left" rowspan="1" colspan="1">All influenza A viruses</td>
    <td valign="top" align="left" rowspan="1" colspan="1">All influenza A and B viruses</td>
    <td valign="top" align="left" rowspan="1" colspan="1">All influenza A viruses</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Efficacy</td>
    <td valign="top" align="left" rowspan="1" colspan="1">At least 75% effective against symptomatic influenza infection</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Better than that of current seasonal influenza vaccine</td>
    <td valign="top" align="left" rowspan="1" colspan="1">At least 70% effective against symptomatic influenza infection</td>
    <td valign="top" align="left" rowspan="1" colspan="1">At least 70% effective</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Target population</td>
    <td valign="top" align="left" rowspan="1" colspan="1">All age groups</td>
    <td valign="top" align="left" rowspan="1" colspan="1">&gt;6 weeks, no upper age limit including high risk groups</td>
    <td valign="top" align="left" rowspan="1" colspan="1">&gt;6 weeks, no upper age limit including high risk groups</td>
    <td valign="top" align="left" rowspan="1" colspan="1">&gt;6 weeks, no upper age limit</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Duration of protection</td>
    <td valign="top" align="left" rowspan="1" colspan="1">At least 1 year</td>
    <td valign="top" align="left" rowspan="1" colspan="1">At least 5 years</td>
    <td valign="top" align="left" rowspan="1" colspan="1">3â€“5 years</td>
    <td valign="top" align="left" rowspan="1" colspan="1">At least 1 year</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>NIAID, National Institute of Allergy and Infectious Diseases (
    <ext-link ext-link-type="uri" xlink:href="https://www.niaid.nih.gov/diseases-conditions/universal-influenza-vaccine-research" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.niaid.nih.gov/diseases-conditions/universal-influenza-vaccine-research</ext-link>); BMGF, Bill and Melinda Gates Foundation (
    <ext-link ext-link-type="uri" xlink:href="https://gcgh.grandchallenges.org/challenges" xmlns:xlink="http://www.w3.org/1999/xlink">https://gcgh.grandchallenges.org/challenges</ext-link>). WHO, World Health Organization (
    <ext-link ext-link-type="uri" xlink:href="https://apps.who.int/iris/bitstream/handle/10665/258767/9789241512466-eng.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">https://apps.who.int/iris/bitstream/handle/10665/258767/9789241512466-eng.pdf</ext-link>; 
    <ext-link ext-link-type="uri" xlink:href="https://jsessionid=37D9E056C3EA58A90EE237432AA7D65F?sequence=1" xmlns:xlink="http://www.w3.org/1999/xlink">https://jsessionid=37D9E056C3EA58A90EE237432AA7D65F?sequence=1</ext-link>)
   </italic>.
  </p>
 </table-wrap-foot>
</table-wrap>
